Core Content Review

Absence seizures (July 2019)

Acne treatment - systemic - 3Qs (January 2022)

Acne treatment - topical - 6Qs (January 2022)

Acute hypertensive complications - 2Qs (May 2022)

Acute ischemic stroke - management - 4Qs (January 2019)

ACE inhibitor and ARB use in diabetes (July 2018)

ACE-inhibitor-associated cough (November 2022)

Acetaminophen overdose - 2Qs (September 2021)

Acetaminophen toxicity - 3Qs (May 2021)

Acromegaly - 2Qs (May 2023)

Acute bacterial sinusitis - 2Qs (March 2023)

Acute gout - 2Qs (May 2021)

Acute kidney injury - 4Qs (July 2019)

Acute management of blood pressure in stroke - 2Qs (July 2020)

Acute myocardial infarction - algorithm (September 2020)

Acute uncomplicated left-sided diverticulitis - 3Qs (May 2022)

Adverse drug reactions in the elderly (July 2022)

Adverse effects of opioid therapy - 3Qs (March 2023)

Alcoholic hepatitis - 3Qs (May 2022)

Alpha-1 reductase inhibitors and prostate cancer (May 2021)

Amiodarone - 2Qs (May 2021)

Amyotrophic lateral sclerosis - 3Qs (July 2022)

Anal fissure - 2Qs (March 2023)

Anemia in children - 3Qs (May 2020)

Angiotensin-converting enzyme inhibitor cough (January 2023)

Antibiotics and COPD (July 2020)

Antibiotic interactions - 3Qs (September 2018)

Anticholinergic toxicity (July 2019)

Anticoagulation and the surgical patient (January 2020)

Antidepressants - 2Qs (November 2020)

Antidepressants and sexual dysfunction - 2Qs (May 2020)

Antioxidants and Alzheimer's Dementia (November 2022)

Antiplatelet therapy and acute coronary syndrome (July 2021)

Anxiety in adults - 3Qs (November 2019)

Anticoagulation after venous thromboembolism (May 2023)

Aortic dissection - 2Qs (May 2020)

Aspirin and pre-eclampsia (November 2022)

Aspirin and primary prevention of cardiovascular disease - 2Qs (September 2019)

Aspirin therapy (September 2023)

Aspirin therapy and diabetes (May 2019)

Aspirin therapy in diabetics (September 2021)

Asthma guideline update - 2Qs (March 2021)

Asthma - management - 2Qs (January 2020)

Asthma in young children - 2Qs (January 2020)

Asthma treatment - 3Qs (July 2018)

Athletes and attention deficit hyperactivity disorder (January 2023)

Atrial fibrillation - rate versus rhythm control (November 2020)

Atrial septal defects (November 2019)

Atopic dermatitis - 3Qs (March 2020)

Atopic dermatitis in children - 2Qs (March 2020)

Atrial fibrillation and anticoagulation - 2Qs (March 2022)

Attention deficit-hyperactivity disorder in adults - 3Qs (July 2018)

Atypical antipsychotic overdose (March 2023)

Autoimmune hepatitis - 2Qs (July 2022)

Avascular necrosis of the hip - 2Qs (September 2021)

Bell's palsy - 2Qs (May 2019)

Barretts esophagus - 3Qs (July 2022)

Barretts esophagus - 2Qs (March 2019)

Bempedoic acid (May 2023)

Benign prostatic hyperplasia - 2Qs (November 2022)

Benign prostatic hyperplasia - 3Qs (January 2019)

Beta-blockers and cardiovascular disease - 2Qs (November 2018)

Beta-blockers in heart failure (May 2022)

Beta-blockers - Perioperative (May 2020)

Bipolar disorder - 2Qs (September 2020)

Bisphosphonates - duration of treatment (January 2019)

Bisphosphonate management (September 2020)

Blepharitis (January 2023)

Bone mineral density testing (January 2022)

Breast cancer - chemoprophylaxis - 3Qs (September 2022)

Breast cancer - chemoprophylaxis - 3Qs (July 2019)

Breast cancer - Genitourinary symptoms - 3Qs (January 2019)

Bullous pemphigoid (November 2022)

Bundle branch block (July 2021)

Cannabidiol (March 2021)

Cannabidiol (CBD) (September 2020)

Cardiac resynchronization therapy (November 2022)

Carpal tunnel syndrome - 3Qs (July 2022)

Cat scratch disease (September 2019)

Celiac disease - 2Qs (May 2023)

Central serous chorioretinopathy (November 2019)

Chlamydia in the newborn (January 2020)

Chlamydia trachomatis infection - 3Qs (January 2022)

Cholestatic pruritis - 2Qs (November 2019)

Choosing Wisely (March 2023)

Chorioamnionitis (September 2021)

Chronic hypertension and pregnancy - 3Qs (March 2020)

Chronic idiopathic urticaria (May 2023)

Chronic kidney disease - 2Qs (May 2022)

Chronic lymphocytic leukemia - 5Qs (July 2020)

Cirrhosis management - 3Qs (July 2018)

Clostridioides difficile infection (September 2023)

Clostridioides difficile - 3Qs (November 2021)

Clostridium difficile in children (November 2018)

Clostridium difficile - overview - 2Qs (November 2018)

Clostridium difficile - treatment -2Qs (September 2018)

Cluster headache - 3Qs (July 2022)

Cluster headache - 2Qs (September 2021)

Cocaine Toxicity - 2Qs (November 2020)

Common cold - treatment (January 2022)

Common cold - treatment (September 2022)

Community-acquired pneumonia - 2Qs (March 2022)

Community-acquired pneumonia in adults - outpatient - 2Qs (January 2020)

Community acquired pneumonia in children - 2Qs (January 2023)

Community-acquired pneumonia - inpatient - 2Qs (January 2020)

Complex regional pain syndrome - 3Qs (September 2021)

Congenital syphilis - 3Qs (January 2023)

Constipation in older adults - 2Qs (November 2021)

Contraception and cardiovascular disease - 2Qs (May 2019)

Contraception and neurologic disease - 2Qs (March 2019)

Contraceptives in adolescents (July 2019)

Contraception in women with diabetes - 2Qs (May 2019)

Contraception and stroke risk (May 2023)

COPD and Roflumilast (September 2018)

COPD maintenance therapy - 2Qs (July 2022)

CoQ10 supplementation (September 2021)

Corticosteroid-induced hyperglycemia - 3Qs (November 2019)

Corticosteroid use for COPD exacerbations (May 2022)

COVID - oral treatment - 2Qs (September 2023)

COVID-19 - oral treatment (May 2022)

Crohn's disease - 3Qs (March 20203)

Crohn's disease - 3Qs (March 2019)

Croup - 2Qs (January 2023)

Cyanotic heart disease - 4Qs (March 2020)

Dengue - 2Qs (May 2023)

Dengue - 2Qs (July 2020)

Deprescribing proton pump inhibitors - 2Qs (July 2022)

Deprescribing proton pump inhibitors - 2Qs (January 2021)

Depression in adolescents (September 2019)

Depression in pregnancy - 3Qs (May 2021)

Dermatomyositis - 2Qs (January 2021)

Depression and cardiovascular disease - 2Qs (January 2022)

Diabetes - adding insulin - 2Qs (March 2022)

Diabetes and chronic kidney disease - 3Qs (July 2021)

Diabetes in children (November 2020)

Diabetes - individualization of medications - 3Qs (November 2019)

Diabetic ketoacidosis - 4 Qs (July 2021)

Diabetic kidney disease - 2Qs (March 2022)

Diabetes mellitus type 2 – prevention - 3Qs (May 2019)

Diabetic retinopathy - 2Qs (January 2022)

Dilated cardiomyopathy - 3Qs (March 2023)

Diclofenac gel - 2Qs (September 2022)

Diethelstibestrol exposure (September 2022)

Digoxin toxicity (May 2022)

Digoxin toxicity (November 2018)

Discoid lupus (January 2023)

Discontinuing contraception (January 2021)

Drug-induced angioedema - 2Qs (January 2019)

Drug-induced dermatology - 3Qs (January 2020)

Drug induced lung injury -2 Qs (March 2023)

Drug-induced thrombocytopenia - 2Qs (January 2023)

Dyspepsia - 2Qs (September 2021)

Dysphonia - 3Qs (May 2022)

Early onset preeclampsia - 2Qs (September 2021)

Easy practice improvement - COPD - 5Qs (January 2023)

ECG abnormalities and psychotropic medications - 2Qs (January 2022)

Eclampsia prophylaxis (March 2020)

Eczema - Dyshidrotic (March 2020)

Ehrlichiosis - 2Qs (May 2022)

Elevated ammonia level - 2Qs (March 2022)

Emergency contraception - 4Qs (May 2019)

Enteric fever (Typhoid and Paratyphoid) - 2Qs (November 2020)

Eosinophilia - 2Qs (May 2020)

Epidural anesthesia in labor - 2Qs (May 2020)

Epidural injection for back pain (January 2022)

Epilepsy in pregnancy - 2Qs (September 2021)

Epilepsy and pregnancy - 2Qs (July 2020)

Erectile dysfunction - 2Qs (January 2021)

Erythema multiforme (November 2019)

Erectile dysfunction - 4Qs (January 2019)

Eustachian tube dysfunction (July 2022)

Evaluation of fever in critically ill patients - 5Qs (January 2021)

Evaluation of the patient with bleeding - 4Qs (January 2019)

Extrapulmonary tuberculosis - 3Qs (November 2022)

Febrile seizures - 2Qs (May 2020)

Fibrates - 2Qs (January 2022)

Fluoroquinolones - adverse effects (July 2019)

Fluoroquinolones - adverse effects - 2Qs (November 2018)

Frontotemporal dementia - 2Qs (July 2019)

G6PD deficiency - 5Qs (March 2021)

Galactogogues (November 2022)

Gastroesophageal reflux in children - 2Qs (May 2023)

Gastroesophageal reflux disease – infants (May 2019)

Gastroparesis - 3Qs UPDATED (January 2023)

Gastroparesis - 3Qs (May 2020)

Gingival hyperplasia (November 2018)

Globus sensation (May 2022)

Glycemic control - 3Qs (May 2019)

Gout - 4Qs (September 2020)

Graves disease - 2Qs (July 2020)

Group B strep - early onset disease - 2Qs (January 2020)

Group B strep - late onset disease (January 2020)

Group B strep screening and prophylaxis - 3Qs (January 2020)

Gynecomastia (July 2022)

Gynecomastia - 3Qs (September 2019)

H. pylori - diagnosis - 2Qs (July 2022)

Headache in pregnancy - 3Qs (July 2019)

Heart failure - 2Qs (July 2021)

Heart failure - Acute - 2Qs (July 2020)

Heart failure - medical treatment - 5Qs (July 2020)

Heart failure with preserved ejection fraction - 3Qs (May 2021)

Helicobacter pylori - 2Qs (November 2019)

Heparin-induced thrombocytopenia (March 2021)

Hepatitis A pre- and post-exposure prophylaxis - 2Qs (UPDATE January 2021)

Hepatitis A - pre- and post-exposure prophylaxis - 2Qs (March 2019)

Hepatitis C treatment - 2Qs (January 2021)

Herpes zoster - 2Qs (November 2022)

Herpes zoster - 3Qs (November 2021)

Herpes zoster opthalmicus (September 2021)

Herpetic Esophagitis - 3Qs (November 2019)

Heroin (July 2018)

Hiccups (November 2019)

HIV and contraception (July 2022)

HIV in children - 4Qs (September 2022)

HIV in older adults (March 2020)

HIV during pregnancy and in infants - 2Qs (March 2020)

Hospital care - delerium (September 2022)

HPV - Vaccines and Indications - 2Qs (November 2020)

Human bite injuries - 2Qs (July 2019)

Hyalurons (January 2020)

Hydroxyurea and sickle cell disease - 2Qs (January 2019)

Hypercalcemia - 5Qs (May 2021)

Hyperemesis gravidarum - 2Qs (November 2021)

Hyperglycemia - Medication-induced - 2Qs (September 2019)

Hyperlipidemia - nonstatin treatment - 2Qs (November 2022) - UPDATED

Hyperlipidemia - nonstatin treatment (September 2020)

Hypomagnesemia - 2Qs (January 2023)

Hypersomnia - 2Qs (May 2019)

Hyperosmolar hyperglycemic state - 2Qs (November 2020)

Hyperparathyroidism - 2Qs (July 2020)

Hyperphosphatemia (January 2021)

Hyperphosphatemia - 2Qs (July 2020)

Hypertension - Gestational - 3Qs (March 2020)

Hypertension in adolescents - 2Qs (September 2020)

Hypertension in the elderly (July 2021)

Hypertriglyceridemia - 2Qs (July 2021) UPDATED

Hypertriglyceridemia - 2Qs (November 2018)

Hypoparathyroidism - 2Qs (November 2019)

Immunizations in those with immunosuppression - 2Qs (September 2020)

Immunization of contacts of immunocompromised individuals (September 2020)

Incretin-based therapy for type 2 diabetes mellitus (July 2018)

Infection of cardiac implantable electronic devices - 2Qs (January 2023)

Induction of labor - 4Qs (September 2020)

Influenza in high risk populations - 3Qs (May 2020)

Influenza in long-term care facilities - 2Qs (May 2020)

Inhaled medications for COPD - 3Qs (July 2023)

Influenza treatment and prophylaxis - 2Qs (March 2022)

Inhaled antimuscarinics - 2Qs (March 2020)

Inhaled steroids in COPD (September 2019)

Insulin types - 3Qs (July 2021)

Intrauterine devices - hormonal (July 2018)

Intrauterine device - insertion - 2Qs (July 2018)

Intrauterine devices - problems/complications (July 2018)

Intrauterine device - removal (July 2018)

Ischemic stroke - management - 4Qs (November 2018)

Ischemic stroke in young adults - 2Qs (March 2021)

Isolated systolic hypertension - 2Qs (May 2020)

Ivabradine and heart failure (July 2020)

JNC-8 recommendations - 3Qs (July 2021)

Klinefelter syndrome - 3Qs (September 2020)

Lactic acidosis (September 2022)

Latent syphilis - 2Qs (November 2021)

Leptospirosis (July 2020)

Leukotriene receptor antagonists (May 2022)

Leukotriene receptor antagonists - 2Qs (November 2018)

Levothyroxine dosing - 3Qs (March 2022)

Levothyroxine drug interactions (January 2022)

Lithium - 2Qs (September 2021)

Lung abscess (September 2022)

Lung injury - Drug-induced - 3Qs (November 2019)

Malaria prophylaxis - 2Qs (March 2022)

Male hypogonadism - 2Qs (November 2018)

Medication adherence (March 2019)

Medications causing heart failure - 5Qs (November 2022)

Medication-related fever (September 2022)

Medications in alcohol treatment - 2Qs (March 2022)

Medication errors in children (May 2019)

Menieres disease - 3Qs (September 2020)

Menstrual migraine - 2Qs (May 2019)

Metformin (September 2021)

Methadone - 3Qs (July 2020)

Microscopic colitis - 2Qs (March 2022)

Migraine - biologic agents (March 2020)

Migraine prophylaxis - 2Qs (November 2018)

Migraine prophylaxis - Pediatric - 2Qs (March 2020)

Migraine - treatment with triptans - 3Qs (September 2019)

Monkeypox - 4Qs (September 2023)

Montelukast - side effects (September 2020)

Multinodular goiter - 3Qs (January 2021)

Multiple sclerosis - treatment - 3Qs (September 2022)

Muscle cramps (September 2022)

Mycobacterium Avium Complex - 2Qs (July 2019)

Naltrexone (September 2020)

Neck-tongue syndrome (May 2022)

Necrotizing enterocolitis in preterm neonates (July 2022)

Needlestick injuries - 3Qs (November 2021)

Neonatal opioid syndrome - 2Qs (March 2021)

Neonatal sepsis (July 2021)

Nephrolithiasis - 3Qs (July 2020)

Nephrolithiasis - medical management - 3Qs (July 2021)

Neuraminidase inhibitors for influenza -3Qs (May 2023)

Neuroleptic Malignant Syndrome - 2Qs (July 2019)

Niacin - 2Qs (November 2022)

Nongastrointestinal manifestations - 3Qs (September 2021)

Non-lipid statin use - 2Qs (November 2021)

NSAIDs and cardiovascular disease - 2Qs (January 2019)

NSAIDs and Pregnancy - 2Qs (May 2021)

Occupational asthma (November 2022)

Occupational asthma - 2Qs (July 2021)

Opioid-induced endocrinopathy - 2Q (November 2021)

Oral allergy syndrome (May 2021)

Oral contraceptives and risk of venous thromboembolism (March 2020)

Orbital cellulitis - 2Qs (September 2022)

Oropharyngeal Candidiasis (July 2019)

Osteoarthritis – management - 2Qs (May 2019)

Osteoarthritis of the shoulder - 2Qs (January 2020)

Osteomyelitis - 3Qs (May 2019)

Osteoporosis - treatment with raloxifene (March 2019)

Pain management for patients taking methadone - 2Qs (May 2023)

Painful diabetic neuropathy - 2Qs (May 2022)

Panic disorder - 3Qs (July 2022)

Parkinson's disease and impulse control disorders (November 2018)

Parkinsons disease - treatment - 2Qs (November 2019)

Pediatric headache - 3Qs (June 2023)

Pelvic inflammatory disease - 3Qs (March 2022)

Penicillin allergy (September 2019)

Performance-enhancing drugs (March 2020)

Peripheral artery disease - 2Qs (May 2022)

Peripheral artery disease - 3Qs (July 2020)

Peripheral polyneuropathy - 2Qs (May 2020)

Persistent depressive disorder - 2Qs (November 2020)

Pertussis - 4Qs (January 2021)

Pilonidal disease - 2Qs (September 2022)

Pneumococcal conjugate vaccine - 13 valent (November 2020)

Pneumococcal conjugate vaccine in adults (November 2020)

Pneumonia - atypical 2 Qs (January 2023)

Post-infectious cough (November 2022)

Postpartum depression - 2Qs (May 2021)

Postural orthostatic tachycardia - 2Qs (July 2020)

Prediabetes in adults - 2Qs (May 2020)

Preexposure prophylaxis in pregnancy (PrEP) (September 2019)

Premature ovarian insufficiency - 3Qs (May 2022)

Premenstrual syndrome and premenstrual dysphoric disorder - 3Qs (May 2022)

Prevention of recurrent stroke - 2Qs (November 2020)

Probiotics (May 2020)

Progestin-only oral contraceptives (March 2020)

Prostatitis - 3Qs (July 2019)

Prosthetic joints and prophylaxis for dental procedures (March 2020)

Pseudogout (July 2021)

Psoriasis - 2Qs (July 2022)

Psoriasis comorbidities - 2Qs (March 2019)

Pterygium, pinguecula (March 2022)

Pulmonary hypertension - 3Qs (March 2022)

Pulmonary sarcoidosis - 3Qs (May 2020)

Ramsay Hunt syndrome (November 2021)

Refractory gastroesophageal reflux disease - 2Qs

Renal artery stenosis - 2Qs (January 2023)

Resistant hypertension - 2Qs (September 2018)

Restless legs syndrome - 2Qs (July 2022)

Retinopathy from hydroxychloroquine (May 2022)

Rh immunoglobulin - 3Qs (September 2022)

Rheumatic fever - acute - 3Qs (March 2022)

Rosacea treatment (January 2022)

Salmonella infection (September 2019)

Schistosomiasis - 2Qs (January 2020)

Schizophrenia - 4Qs (September 2020)

Seasonal affective disorder (May 2021)

Seasonal allergies - management - 2Qs (March 2023)

Selective serotonin reuptake inhibitors (SSRIs) in pregnancy (September 2019)

Serotonin syndrome - 2Qs (September 2020)

SIADH - 2Qs (March 2021)

Simvastatin restrictions (March 2022)

Sinusitis - complications (November 2019)

Sodium-coupled glucose transporter-2 (SGLT2) inhibitors - 2Qs (March 2019)

Soft Tissue Infections - 9 Qs (September 2022)

Solitary functioning kidney in children - 2Qs (January 2019)

Spinal stenosis - 2Qs (September 2022)

Spontaneous bacterial peritonitis - 2Qs (March 2020)

SSRIs and tamoxifen - 2Qs (March 2022)

SSRI use and the effect on the newborn (September 2019)

Statins and diabetes (March 2022)

Statins and primary prevention - 2Qs (July 2019)

Statin side effects - 3Qs (January 2021)

Status epilepticus (September 2019)

Steroid use for preterm labor (September 2018)

Stress ulcer prophylaxis (July 2020)

Stroke risk after transient ischemic attack (March 2023)

Sudden hearing loss - 2Qs (July 2019)

Sudden sensorineural hearing loss - 2Qs (March 2020)

Sulfonylurea overdose - 2Qs (November 2019)

Supplements - Verification - 2Qs (March 2021)

Systolic Blood Pressure Intervention Trial (SPRINT) (November 2018)

Tamoxifen - 2Qs (November 2022)

Tardive syndromes - 3Qs (March 2021)

Tertiary syphilis - 2Qs (January 2022)

Thrombolysis after stroke - 2Qs (March 2020)

Thrombolysis in pulmonary embolism - 2Qs (September 2021)

Thyroid disease in pregnancy - 3Qs (May 2022)

Thyroid medication – dosing - 2Qs (May 2019)

Tinnitus - 3Qs (September 2022)

Tobacco use in pregnancy - 2Qs (July 2022)

Tocolytics - 2Qs (July 2018)

Topical nonsteroidal anti-inflammatory drugs (November 2021)

Tramadol (generic, Ultram) (January 2019)

Tranexamic acid (generic, Lysteda) (March 2019)

Treatment of warts (November 2021)

Treatment of Wheezing - 8Qs (September 2022)

Triptan use (November 2021)

Tuberculosis - latent infection - 2Qs (May 2020)

Tuberculosis - extrapulmonary - 3Qs (January 2019)

Tularemia - 2Qs (September 2019)

Type 1 diabetes in children - 3Qs (September 2020)

Type 1 diabetes mellitus - Pediatric - 2Qs (January 2020)

Type 2 diabetes mellitus - initial management - 3Qs (July 2020)

Type 2 diabetes in children and adolescents - 3Qs (September 2019)

Understanding lipid recommendations - 2Qs (September 2018)

Unprovoked venous thrombosis - 4Qs (November 2019)

Upper respiratory tract infection - treatment - 2Qs (January 2021)

Urethritis (July 2022)

Urinary incontinence - 3Qs (November 2022)

Urinary retention - 2Qs (November 2018)

Use of Varenicline (generic, Chantix) (September 2019)

UTI in children (March 2021)

UTI in nonpregnant women - 2Qs (March 2020)

Venous thromboembolism and malignancy - 2Qs (January 2019)

Vertigo - 2Qs (January 2021)

Vulvovaginal candidiasis in pregnancy (September 2019)

Xerostomia - 2Qs (May 2020)

Yellow fever (March 2023)